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Abstract
Background: Prophylactic use of amoxicillin and amoxicillin/clavulanic acid, although controversial, is common 
in routine clinical practice in third molar surgery. 
Material and Methods: Our objective was to assess the efficacy of prophylactic amoxicillin with or without cla-
vulanic acid in reducing the incidence of dry socket and/or infection after third molar extraction. We conducted 
a systematic review and meta-analysis consulting electronic databases and references in retrieved articles. We 
included double-blind placebo-controlled randomized clinical trials published up to June 2015 investigating the 
efficacy of amoxicillin with or without clavulanic acid on the incidence of the aforementioned conditions after 
third molar extraction. Relative risks (RRs) were estimated with a generic inverse-variance approach and a 
random effect model using Stata/IC 13 and Review Manager Version 5.2.  Stratified analysis was performed by 
antibiotic type.
Results: We included 10 papers in the qualitative review and in the quantitative synthesis (1997 extractions: 
1072 in experimental groups and 925 in controls, with 27 and 74 events of dry socket and/or infection, respec-
tively). The overall RR was 0.350 (p<0.001; 95% CI 0.214 to 0.574). We found no evidence of heterogeneity 
(I2=0%, p=0.470). The number needed to treat was 18 (95% CI 13 to 29). Five studies reported adverse reactions 
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(RR=1.188, 95% CI 0.658 to 2.146, p =0.567). The RRs were 0.563 for amoxicillin (95% CI 0.295 to 1.08, p=0.082) 
and 0.215 for amoxicillin/clavulanic acid (95% CI 0.117 to 0.395, p<0.001).
Conclusions: Prophylactic use of amoxicillin does not significantly reduce the risk of infection and/or dry socket 
after third molar extraction. With amoxicillin/clavulanic acid, the risk decreases significantly. Nevertheless, con-
sidering the number needed to treat, low prevalence of infection, potential adverse reactions to antibiotics and lack 
of serious complications in placebo groups, the routine prescription of amoxicillin with or without clavulanic acid 
is not justified.
Key words: Meta-analysis, amoxicillin, infection, removal, dry socket, third molar.
Introduction
Third molar extraction is a common procedure in oral 
surgery. There still is controversy over the need to rou-
tinely use systemic antibiotics for the prevention of 
infectious and inflammatory complications associated 
with this type of surgery (1,2).
In a survey in 2014 (3), we found that 83% of dentists 
in our region (Bizkaia) would administer antibiotics 
prophylactically for surgery of fully impacted third mo-
lars fully covered by bone in healthy patients, the drugs 
most commonly prescribed being amoxicillin (58.3%) 
and amoxicillin/clavulanic acid (34.5%). Most reviews 
and meta-analyses on this topic question the routine use 
of antibiotics in healthy patients, given that these drugs 
may cause adverse reactions and that their inappropri-
ate use leads to the development of resistant bacteria 
(4-9). In order to assess the scientific evidence on the 
widespread clinical practice among dentists of admin-
istering amoxicillin with or without clavulanic acid be-
fore or during surgery, we have designed a meta-anal-
ysis including all available high quality clinical trials 
on the prophylactic use of amoxicillin with or without 
clavulanic acid.
The objectives of this study were; 1: to assess the effi-
cacy of the use of amoxicillin with or without clavulanic 
acid to prevent infection and/or dry socket, compared to 
a control group given placebo, in third molar surgery 
patients; and 2: to carry out stratified analysis of the ef-
ficacy of amoxicillin and amoxicillin/clavulanic acid. 
We designed a meta-analysis testing the null hypothesis 
that the use of amoxicillin with or without clavulanic 
acid is not effective.
Material and Methods 
This study is reported in accordance with the Preferred 
Reporting Items for Systematic Reviews and Meta-
Analyses (PRISMA) statement and the Institute of 
Medicines’ guidelines. The literature search was based 
on questions structured in the Patient, Intervention, 
Comparison, and Outcome (PICO) format.
- Eligibility criteria: We selected studies including pa-
tients of any age and sex who underwent extraction of 
third molars with any degree of impaction. Regarding 
type of intervention, we included trials that analysed the 
efficacy of amoxicillin with or without clavulanic acid 
at any dose or regimen, and regarding comparisons, we 
exclusively included randomized double-blind placebo-
controlled (RDBPC) clinical trials, not excluding those 
with split-mouth designs. With respect to outcome, we 
excluded studies that did not investigate the incidence of 
dry socket, infection, and both conditions concurrently, 
but did not apply restrictive criteria for the definition of 
infection or dry socket.  Results of interest: The search 
was not restricted by language. The last search date was 
1 June 2015.
- Sources of information. The electronic databases con-
sulted were: Medline/PubMed, Scopus, ScienceDirect, 
Web of Science, Evidence-Based Dentistry, ClinicalTri-
als.gov, the EU Clinical Trials Register, the Cochrane 
Central Register of Controlled Trials, the Spanish Gen-
eral University Board database of doctoral theses in 
Spain (TESEO) and Spanish National Research Council 
(CSIC) bibliographic databases.
- Search strategy: The search terms selected are de-
scriptors of each of the PICO components: extraction, 
removal; third molar; antibiotic, amoxicillin, clavula*; 
infection; and dry socket. The filters used were: humans, 
clinical trials, meta-analysis, randomised, and control-
led trials. The electronic search in the Medline/PubMed 
database was carried out using MeSH strings and search 
algorithms connected with Boolean operators as key 
words for titles and abstracts. Specifically, we used the 
following search strategy: (randomized controlled trials 
OR controlled clinical trial OR randomized controlled 
trials OR random allocation OR double-blind method 
OR clinical trial OR clinical trials OR) (“clinical trial”) 
OR (doubl* OR trebl* OR tripl*) AND (mask* OR 
blind*) OR (“Latin square” ) OR placebos OR placebo* 
OR random* OR research design OR comparative study 
OR evaluation studies OR follow-up studies OR pro-
spective studies OR cross-over studies OR control* OR 
prospectiv* (OR volunteer* NOT animal) AND (third 
molar) AND (antibiotic OR amoxicillin OR clavula*) 
AND (infection OR dry socket) AND (extraction OR 
removal). For the Spanish language databases, we used 
the following Spanish terms: (antibiótico OR amoxi-
cilina OR clavulan*) AND (infección OR alveolitis 
seca) AND (exodoncia OR extracción). The references 
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in each paper were reviewed, and we also searched for 
conference abstracts. 
- Selection of studies: Two researchers independent-
ly performed the searches in the databases with the 
aforementioned criteria. After applying the filters, we 
obtained the following: 26 papers from PubMed; 123 
from SCOPUS; 668 from ScienceDirect; 69 from the 
Web of Science; 65 from Evidence-Based Dentistry, 42 
from the Cochrane Library, 4 from TESEO, and 2 from 
IME-Biomedicina (a CSIC database). The databases not 
listed did not yield any relevant publications. Having re-
moved duplicate publications and any for which it was 
clear from the title and abstract that they did not met the 
inclusion criteria, 75 papers were retrieved, and these 
were reviewed by two of the authors. Table 1 summa-
rises the 65 studies excluded and the reasons for their 
exclusion. Qualitative and quantitative analysis was 
conducted considering the remaining 10 papers (RD-
BPC studies).  
- Data extraction process: Data were extracted on 13 
variables from each of the studies (10-19). Each study 
was examined independently by two researchers.
- List of data: The types of data collected are listed in 
table 2 and 2 continue.
Risk of bias in individual studies. Qualitative and quan-
titative data were collected on potential sources of bias 
in each of the studies (Table 2 and 2 continue). To assess 
bias in each study, we considered the following factors:
1- Generation of the random sequence: we assessed 
whether the method for generating the random sequence 
was appropriate.  
2- Concealment of allocation: we assessed how patients 
were allocated to each group (experimental and control) 
and how allocation was concealed.
3- Blinding of participants and personnel: all the stud-
ies included claimed to be double blind, but they did 
not report the method for blinding of participants and 
personnel.
4- Blinding of outcome assessment: as above, though 
all the studies included claimed to be double blind, they 
did not specify the method for blinding assessment of 
the outcome.
5- Handling of data: we identified whether patients lost 
to follow-up were included in the analysis and whether 
the analysis was carried out on an intention-to-treat ba-
sis.
6- Selective reporting: we checked whether data were 
in fact reported for all the variables and outcomes that 
authors had planned to report a priori.
7- Other sources of bias: we sought to identify other po-
tential sources of bias.
For each study, all of these factors were analysed and 
the study was then assigned to one of three categories 
(low risk, unclear risk, high risk) based on the estimated 
risk of bias.  
- Summary measure of efficacy: the analysis of efficacy 
was based on the relative risk (RR) or cumulative inci-
dence ratio in the treatment vs. control groups. In clini-
cal trials that compared several experimental groups us-
ing the same antibiotic under different regimens with a 
single control group, the data considered were the total 
numbers of surgical interventions and complications in 
the experimental groups, without considering them as 
independent clinical trials. To assess the clinical signifi-
cance of the treatment effect, we used the difference in 
the incidence or attributable risk of infection and calcu-
lated the number needed to treat (NNT) to prevent one 
case of infection.
- Synthesis of results: All the analyses were carried 
out using StataCorp 2013 Stata Statistical Software: 
Release 12 (College Station, TX: StataCorp LP) and 
Review Manager (RevMan) Version 5.2 (Copenhagen: 
The Nordic Cochrane Centre. The Cochrane Collabora-
tion, 2012).  We studied the heterogeneity of the differ-
ent studies using the I2 statistic, an expression related 
to Cochran’s Q test. The overall relative risk, the result 
from combining data from the different studies, was 
calculated using an inverse-variance approach with a 
random effect model. Empirical correction was used for 
the studies with zero effect sizes in one of their arms. 
Any studies with a zero effect size in both arms were 
excluded. The clinical significance was analysed by cal-
culating the NNT for each study and overall.
- Risk of between-study bias. The publication bias was 
assessed graphically using a funnel plot and quantita-
tively with the methods of Egger and Macaskill. The 
number of unpublished studies was estimated with 
Rosenthal’s method.
- Additional analysis: We also carried out meta-analysis 
stratified by the type of antibiotic and cumulative meta-
analysis by publication date, as well as analysing ad-
verse reactions.
 
Results
- Selection of studies: Out of the 75 studies retrieved, 
qualitative and quantitative analysis was performed on 
10 RDBPC studies. Table 1 lists the studies excluded 
and the reasons for their exclusion.
- Characteristics of the studies: Table 2 and 2 continue 
lists the main characteristics of the 10 RDBPC studies 
published between 2001 and June 2015 that were includ-
ed in the qualitative and quantitative analyses.
- Risk of bias in the studies: (Fig. 1) illustrates the esti-
mated risk of bias in each of the studies. Despite poten-
tial sources of bias having been identified, none of the 
RDBPC studies were excluded for this reason.
- Results of the individual studies: The forest plot (Fig. 
2) is a graphical representation of the estimates of the 
RRs and 95% CIs based on the samples in each of the 
studies, together with their relative weights. Forest plots 
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1 Abu-Mowais 1990 Not a double-blind study 
2 Adde 2012 No placebo control group  
3 Agrawal 2012 Did not assess the response variable infection   
4 Al-Asfour 2009 Retrospective study 
5 Ariza 1999 Not a randomised study 
6 Arora 2014 No control group exclusively treated with placebo  
7 Ataoglu 2008 Not a double-blind study 
8 Barclay 1987 Used metronidazole 
9 Bargnesi 1995 Surgical procedures included other than just third molar extractions   
10 Bergdahl 2004 Used  metronidazole 
11 Bystedt  1980 Used azidocillin, erythromycin, clindamycin and doxycycline 
12 Bystedt  1981a Used  phenoxymethylpenicillin and azidocillin 
13 Bystedt  1981b Used  tinidazole 
14 Calvo 2012 Did not assess the effect of the antibiotic   
15 Cubas-Jaeger 2015 No placebo control group  
16 Curran 1974 No placebo control group  
17 De Moura 2011 No placebo control group  
18 Delibasi 2002 Not a double-blind study 
19 Foy 2004 Not a randomised study 
20 Fernández 2002 No control group 
21 Fridrich 1990 Not a randomised study 
22 Graziani 2005 Not a double-blind study 
23 Grossi 2007 Did not consider infection as a response variable   
24 Halper2007 Used  penicillin IV 
25 Happonen 1990 Used phenoxymethylpenicillin and tinidazole 
26 Head 1984 Did not consider infection as a response variable   
27 Iglesias-Martin 2014 No control group  
28 Ishihama 2006 Retrospective study 
29 Kaczmarzyk 2007 Used clindamycin 
30 Kaziro 1984 Did not consider infection as a response variable   
31 Kremanov 1980 Not a double-blind study 
32 Kremanov 1981 Not a double-blind study 
33 Kremanov 1986 Not a double-blind study 
34 Laird 1972 No control group 
35 Lee 2013 Retrospective study 
36 Leon Arcila 2001 Not indexed in PubMed 
37 Limeres 2009 No control group 
38 Lloyd 1994 No control group 
39 Lombardia Garcia 1987 Not a double-blind study 
40 Lopes 2011 Not a double-blind study 
41 Luaces-Rey 2010 No control group 
42 Lyall 1991 Not a double-blind study 
43 MacGregor 1973 Used topical antibiotic  
44 Milani 2015 No control group exclusively treated with placebo 
45 Mitchell 1986 Used timidazole 
46 Mitchell 1987 No control group 
47 Monaco 1999 Not a double-blind study 
48 Monaco 2009 Not a double-blind study 
49 Olusanya 2011 No control group 
50 Osborn 1979 Not a randomised study 
51 Poeschl 2004 Not a double-blind study 
52 Ritzau 1992 Used metronidazole 
53 Reekie 2006 Used topical antibiotic 
54 Rohit 2014 No placebo control group 
55 Rood 1979 Not a randomised study 
56 Samsudin 1994 Not a randomised study 
57 Sane 2014 No placebo controlled group  
58 Sekhar 2001 Used metronidazole 
59 Sisalli 2012 No control group  
60 Stavropoulos 2006 Used a topical antibiotic 
61 Sulejmanagic 2005 Not a randomised study  
62 Swanson 1989 Used a topical antibiotic  
63 Uluibau 2005 Not a double-blind study 
64 Yoshii 2002 Not a double-blind study 
65 Xue 2014 Pilot study  
Table 1. Studies excluded from the meta-analysis and the reasons for their exclusion.
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Main author 
(Year) 
Study location 
Recruitment 
period 
Antibiotic  
Analgesic/ 
Anti-inflammatory/ 
antiseptic drugs 
Criteria for diagnosis of 
infection  Antibiotic regimen 
Quantitative outcome 
measure  
Scheduled postoperative 
appointments   
Randomisation method 
Adverse reactions Losses to follow-up  
Arteagoitia (10) 
(2015) 
Spain 
February 2010 to 
June 2013 
Amoxicillin /clavulanic 
acid 
 
Ibuprofen 600 mg q8h 
for 7 days after surgery  
Chlorhexidine 
mouthwash 0.12% 15 
ml q8h for 7 days after 
surgery  
Concentration of C reactive 
protein >2.2 mg/dL; Oral 
temperature >37.8º intraoral 
abscess draining pus; severe 
pain that persists or 
increases 48 h after surgery 
together with intraoral 
inflammation and/or 
intraoral erythema; severe 
pain 7 days after surgery 
together with intraoral 
inflammation and/or 
intraoral erythem 
E (n=60): oral amoxicillin 
/clavulanic acid 2000/125 
mg 2 hours before surgery 
+  oral amoxicillin / 
clavulanic acid 2000/125 
mg  q12h for 4 days after 
surgery  
C (n=58): oral placebo 2 
hours before surgery + 
oral placebo q12 h for 4 
days after surgery  
E : 3.33% (2/60) 
C : 8.62% (5/58) 
 
7 days after surgery 
 
Using C4-SDP software 
(Glaxo S.A., Tres Cantos, 
Madrid, Spain) 
E: 12 patients 
(nausea and vomiting 
1; diarrhoea 8; 
abdominal pain 1; 
vaginal candidiasis 2; 
others 0) 
C: 2 patients 
(nausea and vomiting 
0; diarrhoea 1; 
abdominal pain 0; 
vaginal candidiasis 0; 
Others 1) 
4 patients lost 
to follow-up, 
C:3 and E:1 
 
Arteagoitia (11) 
(2005) 
Spain 
March 2001 to 
February 2003. 
Amoxicillin /clavulanic 
acid 
 
Diflunisal 500 mg q12h 
for 2 days. Metamizole 
575mg q8h (if moderate 
to severe pain). 
Chlorhexidine 
mouthwash 0.12% 15ml 
q8h for 7 days after 
surgery   
Oral temperature >37.8º; 
intraoral abscess draining 
pus; severe pain that persists 
or increases 48 h after 
surgery together with 
intraoral inflammation 
and/or intraoral erythema; 
severe pain 7 days after 
surgery together with 
intraoral inflammation 
and/or intraoral erythema 
 
E (n=259): oral 
amoxicillin /clavulanic 
acid 500/125 mg q8h for 4 
days after surgery  
 
C (n=231): placebo 
following the same 
regimen   
E : 1.93% (5/259) 
C : 12.99% (30/231) 
 
7 days after surgery 
 
Using C4-SDP software 
(Glaxo S.A., Tres Cantos, 
Madrid, Spain 
E: 14 patients 
C: 2 patients 
 
All adverse reactions 
were mild: 
 2 people with 
vomiting, 2 stomach 
ache, 1 mycosis, and 
11 with diarrhoea. 
4 patients lost 
to follow-up, (2 
in each group): 
all for failing to 
attend 
postoperative 
appointments  
Bezerra (12) 
(2011) 
Brazil 
January 2008 to 
November 2008 
Amoxicillin  
 
Nimesulide 100 mg 
q12h for 4 days after 
surgery. Paracetamol 
500 mg q6h for 2 days 
after surgery. 
Infection: purulent 
discharge, alveolitis and 
body temperature >37.5ºC 
Dry socket: postoperative 
pain at the extraction site, 
that increases between day 1 
and 3 after surgery, together 
with total or partial 
disintegration of the blood 
clot in the socket, with or 
without halitosis 
E (n=68): oral amoxicillin 
1 g 1 h before surgery   
C  (n=68): oral placebo 1 
h before surgery   
E : 1.47% (1/68) 
C : 5.88% (4/68) 
 
3, 7 and 14 days after 
surgery 
 
By the tossing of a coin by 
a blinded researcher 
Not described 
9 declined to 
participate, 1 
for failed to 
attend 
postoperative 
appointmentsr1 
for pregnancy 
 
Bortoluzzi (13) 
(2013) 
Brazil 
Not specified 
Amoxicillin  
 
Paracetamol 750 mg 
q6h for 2 days after 
surgery.  
Diclofenac 50 mg q8h 
for 2 days after surgery   
 
Criteria applied for the 
diagnosis of dry socket and 
alveolar infection are the 
same as those previously 
described by other authors 
(Arteagoitia et al. and 
Bouloux et al.). 
E1 (n=12): oral 
amoxicillin 2 g + 
dexamethasone 8 mg 60-
90 min before surgery  
E2 (n=12): oral 
amoxicillin 2 g + placebo 
8 mg 60-90 min before 
surgery 
E3 (n=14): oral placebo 2 
g + dexamethasone 8 mg 
60-90 before surgery 
C (n=12): oral placebo 2 g 
+ placebo 8 mg 60-90 min 
before surgery  
E1 : 0% (0/12) 
E2 : 8.33% (1/12) 
E3 : 7.14% (1/14) 
C : 8.33% (1/12) 
 
Not specified 
 
By draw 
Not described Not described 
Bulut (14) 
(2001) 
Turkey 
Not specified 
Amoxicillin  
 
Paracetamol (not 
specifying treatment  
regimen). 
Post-operative C reactive 
protein levels >10 mg/l and 
alpha-1 antitrypsin levels 
>370 mg/dl in blood 
considered indicators of 
infection 
E (n=30): oral amoxicillin 
1000 mg 60 min before 
surgery (8:00 a.m.) + 
amoxicillin 500 mg at 
4:00 p.m. and 12:00 p.m. 
after surgery + oral 
amoxicillin 500 mg q8h 
for 4 days after surgery   
C (n=30): placebo  
E : 6.67% (2/30) 
C : 6.67% (2/30) 
 
1,3 and 7 days after 
surgery 
 
Not described   
Not described Not described 
Table 2. Main characteristics of the 10 randomized double-blind placebo-controlled studies included in the qualitative analysis. 
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E: experimental group, C: control group, n=number of third molars extracted.
- In studies with a split-mouth design (those of Bezerra, Siddiqi, Bulut and Xue), the rates of infections have been calculated taking 
n as the number of third molars removed, rather than the number of patients in the study. 
- In studies using antibiotics other than amoxicillin for patients allergic to this drug, if it was not specified how many patients were 
treated with alternative antibiotics, calculations have been based on assuming that all patients were treated with amoxicillin or 
amoxicillin/clavulanic acid.
Lacasa (15) 
(2007) 
Spain 
January 2002 to 
December 2002 
Amoxicillin /clavulanic 
acid  
 
Metamizole 575 mg q8h 
for at least 2 days after 
surgery.   
 Purulent discharge in the 
alveolus and/or excessive 
inflammation with 
fluctuation with/without pain 
- Local abscess.  
- Facial  or neck cellulitis  
and other signs of infections 
such as pain, heat, redness 
and/or fever 
- Osteitis defined as absence 
of absence of blood clot of 
the orifice and presence of a 
putrid smell and intense 
neuralgic type pain 
E1 (n=75): oral 
amoxicillin/clavulanic 
acid 2000/125 mg before 
surgery + placebo for 5 
days after surgery  
E2 (n=72): oral placebo 
before  surgery + oral 
amoxicillin/clavulanic 
acid 2000/125 mg for 5 
days after surgery  
C (n=75): placebo before 
and after surgery, under 
the same conditions as 
experimental groups   
E1 : 5.33% (4/75) 
E2 : 2.78% (2/72) 
C : 16.00% (12/75)  
 
1, 3 and 7 days after 
surgery 
 
Described as randomised, 
randomisation method not 
specified 
 
 
 
E1: 48% of patients 
had some type of 
adverse reaction  
E2: 54.7% of patients 
had some type of 
adverse reaction  
C: 69.3% of patients 
had some type of 
adverse reaction  
 
E2: 3 patients 
lost to follow-
up at day 1,  as 
they withdrew 
their consent 
(before day 1 
assessment)  
Lopez-Cedrún (16) 
(2011) 
Spain 
Not specified 
Amoxicillin  
 
Ibuprofen 600 mg 
immediately after 
surgery + ibuprofen 600 
mg q12h for 5 days. 
Metamizole 2 g (rescue 
analgesia) 
Salt water mouth rinse 
after meals  
- Infection: purulent 
discharge and/or excessive 
inflammation with or 
without pain. Palpable 
nodules in neck and facial or 
neck cellulitis.   
- Dry socket: disintegration 
of blood clot in the alveolus 
and halitosis, as well as 
severe neuropathic pain 
E1 (n=39):  amoxicillin 
2000 mg orally 2 h before 
surgery  + placebo q8h for 
5 days after surgery  
E2  (n=44): placebo 2 
hours before surgery + 
amoxicillin 500 mg q8h 
for 5 days after surgery   
C  (n=40): placebo 2 h 
before surgery + placebo 
q8 h for 5 days after 
surgery   
E1 : 0% (0/39) 
E2 : 0% (0/44) 
C : 12.50% (5/40) 
 
7 days after surgery 
 
By a pharmacists using a 
random alphanumeric 
code  
 
E1:nausea 1;diarrhoea 
2; stomachache 
3;cutaneous eruption 
1, headache 1,others 5 
E2:vomiting 1; 
nausea 1; diarrhoea 1; 
stomach ache 2; 
cutaneous eruption 
1;headache 1, others 
3. C: nausea 
2;diarrhoea 1; 
stomach ache 1; 
headache 3;others 7 
E1: 3 lost to 
follow-up,2 for 
technical 
problems; C: 4 
lost to follow-
up,1 for 
technical 
problems;  
E2:1 lost to 
follow up  
Pasupathy (17) 
(2011) 
India 
Not specified 
 
Amoxicillin  and 
metronidazole  
 
Ibuprofen 600mg q8h 
for 5 days after surgery.  
- Increase in body 
temperature   
- Purulent discharge from 
the wound   
E1 (n=31): oral 
amoxicillin 1g 1 h before 
surgery   
E2  (n=29): oral  
metronidazole 800 mg 1h  
before surgery  
C  (n=29): placebo 
E1 : 6.45% (2/31) 
E2 : 0% (0/29) 
C : 10.33% (3/29) 
 
7 days after surgery 
 
Using a table created 
using Random Software 
(version 2, Social 
Psychology) 
Not described 
9 patients were 
excluded from 
the analysis: 8 
lost to follow-
up and 1 for 
using 
antibiotics 
during the 
follow-up 
period. 
Siddiqi (18) 
(2010) 
New Zeeland 
Not specified 
Amoxicillin  
Ibuprofen 400 mg 
before surgery + 
ibuprofen 400 mg q6h 
for 2 days after surgery 
Paracetamol 500 mg + 
codeine phosphate 8 mg 
q6h for 2 days after 
surgery 
Chlorhexidine 
mouthwash 0.2% 10 ml 
before surgery + 10 ml 
q8h for 3 days after 
surgery 
- Dry socket: halitosis, pain 
and lack of blood clot 
together with bone tissue 
necrosis  
Group 1(n=192): 1st 
appointment: oral 
amoxicillin 1 g 1 h before 
surgery, 2nd   
appointment: placebo 
under the same regimen or 
vice versa  
Group 2(n=188): 1st 
appointment: oral 
amoxicillin 1 g 1 h before 
surgery + amoxicillin 500 
mg q8h for 2 days after 
surgery; 2nd appointment: 
placebo under the same 
regimen or viceversa 
 
E (Group 1 + Group 2): 
1.05% (2/190) 
C  (Group 1 + Group 2): 
2.10% (4/190) 
 
1, 3, 7 and 14 days after 
surgery 
 
By asking patients to 
select one of two 
sequentially-numbered  
Not described 
5 patients lost 
to follow-up 
for failing to 
adhere to the 
follow-up 
protocol  
Xue (19) 
(2015) 
China 
January to 
December 2013 
Amoxicillin 
(clindamycin, if allergy 
to amoxicillin) 
 
Loxoprofen before or 
after operation as 
necessary. 
Not specified 
E  (n=192): oral 
amoxicillin 500 mg 1h 
before surgery + oral 
amoxicillin 500 mg q 8h 
for 3 days after surgery (or 
oral clindamycin 300 mg 
if allergy to amoxicillin)   
C (n=192): placebo at the 
same times before and 
after surgery 
E: 3.13% (6/192) 
C: 4.17% (8/192) 
 
2 and 10 days after 
surgery 
 
Using computer-generated 
random numbers 
E: 12 patients 
(gastrointestinal 
adverse reactions 4; 
ulcers 2, fever 6) 
C: 16 patients 
(gastrointestinal 
adverse reactions 0; 
gastrointestinal 
adverse reactions 2, 
fever 14) 
15 patients 
excluded, but 
the reasons 
were not 
specified  
 
Table 2 Continue. Main characteristics of the 10 randomized double-blind placebo-controlled studies included in the qualitative 
analysis. 
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Fig. 2. Forest Plots.
Overall forest plot: graphical representation of the estimates of the RRs and 95% CIs based on the samples in each of the studies, including both 
those that used amoxicillin and those that used amoxicillin/clavulanic acid, together with their relative weights.
Amoxicillin forest plot.
Amoxicillin/clavulanic acid forest plot. 
Fig. 1. Risk of bias in studies included in the systematic review.
- All the studies were considered low risk in terms of performance and de-
tection bias, given that a double-blind design was a selection criterion for the 
meta-analysis.
- In studies with a split-mouth design, it was considered that that there might 
be other sources of bias given the duration of the washout period (no more than 
4 weeks in all cases). 
Med Oral Patol Oral Cir Bucal. 2016 Jul 1;21 (4):e494-504.                                                                                     Amoxicillin in the prevention of infectious complications after tooth extraction
e501
are shown for the overall analysis and for the analysis 
stratified by antibiotic (amoxicillin or amoxicillin/cla-
vulanic acid).
- Synthesis of the results:
Analysis of the overall efficacy of amoxicillin with or 
without clavulanic acid: The quantitative analysis in-
cluded 1997 extractions: 1072 in experimental groups 
and 925 in control (placebo) groups, with 27 and 74 re-
ported events of dry socket and/or infection respectively. 
The overall RR was found to be 0.350, with a 95% CI of 
0.214 to 0.574, this being significant (p<0.0001) and dif-
ferent from 1, indicating that treatment with amoxicillin 
with or without clavulanic acid prevents the develop-
ment of infectious complications (dry socket, infection, 
or both conditions concurrently).
Analysis of the heterogeneity: The Q statistic was 8.65 
and I2 was 0% (p=0.470), supporting the assumption 
of homogeneity among the studies. Further, there is no 
sign of heterogeneity in the L’Abbé plot (Fig. 3), all the 
circles being grouped close together, independently of 
their size and baseline risk.
Analysis of clinical significance: The NNT for each of 
the studies is reported in table 3 and the overall NNT, 
adjusting for the weight of each study, was estimated 
to be 18 (95% CI 13 to 29). This means that we would 
need to treat between 13 and 29 patients with amoxicil-
lin with or without clavulanic acid to prevent one case 
of infection. 
- Risk of publication bias:  The funnel plot (Fig. 3) is not 
absolutely symmetrical around the summary estimate 
RRw, and hence, given the suspicion that there may 
be publication bias, we carried out the corresponding 
quantitative analysis.
The Begg method suggested a lack of publication bias 
(Kendall s´ Tau being 0.1556; p=0.59), and Egger s´ more 
sensitive method also suggested a lack of publication 
Fig. 3. L'Abbé plot, Funnel plot, Cumulative plot.!
!
AUTHOR YEAR NNT Lower limit Upper Limit 
Bulut  (14)  2001 * * * 
Arteagoitia (11)            2005 9.04 6.37 15.60 
Lacasa (15) 2007 8.39 4.81 33.05 
Siddiqi (18) 2010 95.00 28.11 -68.87 
Bezerra (12) 2011 22.67 9.35 -53.47 
Pasupathy (17) 2011 14.26 5.27 -20.13 
 Lopez Cedrun (16) 2011 8.00 4.40 44.43 
Bortoluzzi (13) 2013 * * * 
Arteagoitia (10) 2015 18.91 7.24 -30.81 
Xue (19) 2015 96.00 20.88 -36.95 
!
Table 3. Number needed to treat (NNT) for each individual study included in the meta-
analysis.
* Since control and experimental groups have identical results, it is impossible to compute 
the NNT.
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bias (with an intercept value of 0.4772, which is not sig-
nificant, p=0.627). Macaskill’s more specific procedure 
yielded a slope that was close to 0 and non-significant 
(p=0.489), confirming the lack of publication bias, both 
when using the sample size (n) as the independent vari-
able, as proposed by Peters, and when the regression 
uses the inverse of the sample size (1/n) as the indepen-
dent variable (p=0.330). Lastly, with Rosenthal’s meth-
od, it was estimated that it would be necessary to add 79 
non-significant studies to cause the results of this meta-
analysis to become non-significant.  
- Additional analysis:
Stratified analysis: We analysed independently the stud-
ies in which the treatment was amoxicillin or amoxicil-
lin/clavulanic acid:
- Amoxicillin: We included 7 studies (1167 extractions: 
606 in experimental groups and 561 in controls with 14 
and 27 events of dry socket and/or infection respectively). 
The RR was 0.563 (p=0.082, 95% CI 0.295 to 1.08). We 
found no evidence of heterogeneity (I2=0.00%, p=0.619). 
The NNT was 40, meaning that about one in every 40 
patients would benefit from the treatment. The 95% con-
fidence interval for the NNT ranged from 22 to 274.
- Amoxicillin/clavulanic acid: We included 3 studies 
(830 extractions: 466 in experimental groups and 364 
in controls with 13 and 47 events of dry socket and/or 
infection respectively). The RR was 0.215 (p<0.001, 
95% CI 0.117 to 0.395). Again, we found no evidence of 
heterogeneity (I2=0.00%, p=0.535). The NNT was 10, 
meaning that about one in every 10 patients would ben-
efit from the treatment, and the 95% confidence interval 
for the NNT ranged from 7 to 16.
Cumulative analysis: Figure 3 shows the evolution of 
the 95% CI of the weighted estimate in the cumulative 
meta-analysis by year of publication, that is, as we add-
ed RDBPC studies to the analysis in date order. It can 
be observed that the first study found a non-significant 
association but that with the progressive addition of the 
studies conducted to date the RR increased towards 1.  
Analysis of adverse reactions: Five studies reported 
adverse reactions (Table 2 and 2 continue) with a total 
follow-up of 1337 patients (741 in experimental groups 
and 596 controls). A total of 222 patients had some type 
of adverse reaction associated with the antibiotic given 
(136 in experimental groups and 86 controls). The RR 
was 1.188 (95% CI 0.658 to 2.146; p=0.567). The ad-
verse reactions were generally mild and short lived. The 
number needed to harm (NNH) was 26, meaning that 1 
in 26 patients given the prophylactic antibiotics would 
have an adverse reaction.
Discussion
Our meta-analysis includes 10 RDBPC clinical trials 
that assess the efficacy of amoxicillin with and without 
clavulanic acid to prevent dry socket, infection and both 
conditions concurrently after third molar extraction. 
These studies yielded a total of 1997 third molar extrac-
tions. We only selected trials that used placebo in the 
control group. It is important to highlight that we have 
not taken into account the antibiotic regimen used. As 
noted in the qualitative analysis, the studies included are 
not free from individual bias, but we have not detected 
publication bias. Adverse reactions were more frequent 
in the experimental group but were generally mild.
In the quantitative analysis, we used a multiplicative 
relative risk model and estimates were weighted by the 
inverse of the variance. We opted to use a random ef-
fect model, which assigns a fixed constant coefficient of 
variability to all studies, and this gives more importance 
to studies with smaller sample size; however, this is the 
most appropriate type of model when analysing fewer 
than 20 studies, provided there is no publication bias. 
We have carried out analysis stratifying by the type of 
antibiotic (amoxicillin or amoxicillin with clavulanic 
acid), finding this variable to be relevant. The hypothe-
sis of the analysis by subgroups was established a priori 
and the variable type of antibiotic used for weighing 
was defined prior to randomisation in all of the stud-
ies. This stratified meta-analysis has found that the 
statistical significance of the RR differs between the 
subgroups: in the case of amoxicillin alone, the CI of 
the RR (95% CI 0.295 to 1.08) includes 1 and the result 
was not significant (p=0.082), while for amoxicillin and 
clavulanic acid, the result was statistically significant 
(p<0.001, 95% CI 0.117 to 0.395). We should emphasize 
that only three studies were included in the amoxicil-
lin/clavulanic acid subgroup analysis, and that two of 
these were conducted by the same research team (10,11), 
which could be a source of bias.
We have not used restrictive criteria in the definition 
of infection or dry socket. We found significant differ-
ences in the rate of infection and/or dry socket in the 
groups treated with placebo. This may be attributable to 
differences in the diagnostic criteria, or factors related 
to the technique used, surgeon experience, asepsis or 
patient characteristics. In our meta-analysis, the mean 
rate of infection in the control group was 8%, with very 
different results across the clinical trials included. The 
mean rates of infection in the placebo group were 5% 
in studies using amoxicillin and 13% in studies using 
amoxicillin/clavulanic acid.
The rate of infection was not significantly different in 
patients given amoxicillin (2.31%) or amoxicillin/cla-
vulanic acid (2.79%). In contrast, there were notable 
differences analysing absolute risk reduction, with val-
ues of 2.50% (95% CI 0.37 to 4.64%) in the amoxicil-
lin group and 10.12% (95% CI 6.37 to 13.88%) in the 
amoxicillin/clavulanic acid group. This discrepancy is 
understandable given the difference in rates of the con-
ditions considered in patients treated with placebo in 
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the two subgroups, with higher rates of infection in the 
case of studies using amoxicillin/clavulanic acid than 
those using amoxicillin (Table 2 and 2 continue). This 
underlines the fact that failing to include placebo groups 
in trials of antibiotics may lead to different conclusions 
regarding drug efficacy (4).
Other meta-analyses have been published on the effica-
cy of antibiotics for the prevention of inflammatory and 
infectious complications after third molar extraction. 
In 2007, Ren et al. (9) studied the efficacy of antibiotic 
prophylaxis including 15 clinical trials. They did not 
limit the search to double-blind studies, included dif-
ferent families of antibiotics and analysed the efficacy 
taking into account the treatment regimen, conclud-
ing that the antibiotic treatment is effective only when 
used before surgery. In 2012, Lodi et al. (6) included 
18 double-blind randomised clinical trials and analysed 
different families of antibiotics and several different 
response outcomes (infection, dry socket, pain, inflam-
mation, trismus and high temperature). They concluded 
that, compared to placebo, antibiotics (without specify-
ing which) reduce the risk of infection by 70%, a very 
similar result to ours (65%), and that of dry socket by 
38%. On the other hand, they found that antibiotics are 
associated with an increase in adverse effects compared 
to placebo (RR 1.98; 95% CI 1.10 to 3.59; p = 0.02). In 
our case, the relative risk was somewhat lower, but only 
half of the studies had recorded adverse reactions (RR 
= 1.188; 95% CI 0.658 to 2.146; p =0.567). Lodi et al. 
(6) estimated that, despite the results obtained, physi-
cians should consider whether treating 12 patients with 
antibiotics to prevent one case of infection does more 
harm than good.
In our case, the results should also make us think. To 
avoid one patient having an infectious complication us-
ing amoxicillin prophylactically, we would need to treat 
40 patients. Moreover, as mentioned earlier, amoxicillin 
does not significantly reduce the risk of infection and/
or dry socket. For this reason, we believe that its use is 
not justified.
In the case of amoxicillin/clavulanic acid, we would 
have to treat 10 patients to avoid 1 case of infectious 
complication. It is important to analyse the clinical sig-
nificance of these results. First, we should take into ac-
count the low rate of infectious complications and the 
lack of serious complications. On the other hand, the 
risks of antibiotic use are widely documented, in rela-
tion to increases in antibiotic resistance at the popula-
tion level (20,21), as well as adverse reactions at the in-
dividual level. In this meta-analysis, 1 out of 26 patients 
treated with amoxicillin with or without clavulanic acid 
had some type of adverse reaction.
For all these reasons, and given our results, we conclude 
that there no basis for recommending the prophylactic 
use of amoxicillin without clavulanic acid for prevent-
ing infection and/or dry socket after third molar extrac-
tion in healthy patients. Regarding amoxicillin/clavu-
lanic acid, although the null hypothesis was rejected 
and prophylactic use was statistically significantly ef-
fective, taking into account the NNT, low rate of infec-
tious complications, adverse reactions in experimental 
groups and lack of serious complications reported in 
controls, the prescription of this combination of antibi-
otics cannot be justified either.
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